期刊文献+

持续非卧床腹膜透析患者心衰发生的危险因素分析 被引量:6

Risk factors of heart failure among continuous ambulatory peritoneal dialysis patients
原文传递
导出
摘要 目的:探讨持续非卧床腹膜透析( CAPD )患者心衰发生的危险因素。方法采用CAPD患者容量管理量表、纽约心脏协会( NYHA)的心功能分级及生化指标等调查分析影响CAPD患者心衰发生的独立危险因素。探讨不同营养状态下,容量管理水平与心衰发生的关系。结果共发放调查问卷114份,收回114份,有效回收率为100%。容量管理水平、血清前白蛋白、尿素氮是引起CAPD患者发生心衰的独立危险因素( r值分别为-1.290,-0.006,0.085;P<0.05)。前白蛋白正常组患者中,容量管理水平与心衰发生率呈负相关(χ2=10.542,P<0.05)。结论提高CAPD患者容量管理水平及透析充分性,重视营养状态的评估,可为预防心衰的发生提供依据。 Objective To explore the risk factors of heart failure among continuous ambulatory peritoneal dialysis (CAPD) patients.Methods General information, scale of volume management of CAPD , New York Heart Association ( NYHA) classification and biochemical data were used to analyze independent risk factors of heart failure among CAPD patients .The relationship between level of volume management and incidence of heart failure was also discussed in different nutritional status .Results A total of 114 questionnaires were handed out and 114 were recovered , with the rate of 100%.Level of volume management , serum pre-albumin, blood urea nitrogen were independent risk factors for heart failure among CAPD patients (r=-1.290,-0.006,0.085, respectively;P<0.05).With a normal level of serum pre-albumin, higher volume management score were associated with lower incidence of heart failure (χ2 =10.542,P<0.05).No differences were found between volume management scores and incidence of heart failure among those with higher or lower serum pre -albumin levels.Conclusions Improvement of the level of volume management and dialysis adequacy as well as attention to assess nutritional status of CAPD patients can provide references for preventing heart failure .
出处 《中华现代护理杂志》 2014年第3期293-296,共4页 Chinese Journal of Modern Nursing
基金 苏州市科技计划项目
关键词 腹膜透析 持续不卧床 心力衰竭 危险因素 Peritoneal dialysis,continuous ambulatory Heart failure Risk factor
  • 相关文献

参考文献14

  • 1Sipahioglu MH, Aybal A, Unal A, et al. Patient and technique survival and factors affecting mortality on peritoneal dialysis on Turkey: 12 years experience in a single center[J]. Petit DialInt ,2008,28 ( 3 ) :238-245. 被引量:1
  • 2Locatelli F, Marcelli D, Conte F, et al. Survival and development of cardiovascular disease by modality of treatment in patients with end-stage renal disease [ J ]. J Am Soc Nephrol, 2001,12 ( 11 ) : 2411-2417. 被引量:1
  • 3Wang X, Axelsson J, Lindholm B, et al. Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients [ J ]. Blood Purif,2005,23 (5) :373-378. 被引量:1
  • 4Kircelli F, Asci G, Yilmaz M, ct al. The impact of strict volume control strategy on patient suivival and technique failure in peritoneal dialysis patients [ J ]. Blood Purification, 2011,32 ( 1 ) :30-37. 被引量:1
  • 5Wang AY, Wang M, Lam CW, et al. Heart failure in long - term peritoneal dialysis patients: a 4-year prospective analysis [ J ]. Clin J Am Socof Nephrol, 2011,6(4) :805-812. 被引量:1
  • 6DeWalt DA, Malone RM, Bryant ME, et al. A heart failure self- management program for patients of all literacy levels: a randomized, controlled trial[ J]. BMC Health Serv Res, 2006,6 : 30. 被引量:1
  • 7Kalantar-Zadeh K, Regidor DL, Kovesdy CP, et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long term hemodialysis [ J ]. Circulation, 2009, 119 (5) :671-679. 被引量:1
  • 8Asci G, Ozkahya M, Duman S, et al. Volume control associated with better cardiac function in long-term peritoneal dialysis patients [ J]. Perit Dial Int, 2006, 26 ( 1 ) : 85-88. 被引量:1
  • 9Wang AY, Wang M, Woo J, et al. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients[J]. J Am Soc Nephml, 2004, 15(8) :2186-2194. 被引量:1
  • 10于晓艳,马增伟,赵宇,庞磊,施莹,谷宝华,李新.腹膜透析并发心力衰竭40例临床分析[J].中国急救医学,2012,32(6):539-541. 被引量:3

二级参考文献11

  • 1Wang AY, Sanderson J, Sea MM, et al. Important factors other than dialysis adequacy associated with inadequate dietary protein and energy intakes in patients receiving maintenance peritonealdialysis[J]. Am J Clin Nutr, 2003, 77(4) : 834 -841. 被引量:1
  • 2Menon MK, Naimark DM, Bargman JM, et al. Long -term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function [ J ]. Nephrol Dial Trans- plant, 2001, 16(11): 2207-2213. 被引量:1
  • 3Woodrow G. Methodology of assessment of fluid status and ultrafil- tration problems[ J]. Perit Dial Int, 2007, 27 (Suppl 2) : S143 - S147. 被引量:1
  • 4Liu FY, Xiao L, Peng YM, et al. Small interfering RNA inhibi- tion of CTGF by retroviral delivery attenuates profibrotic the effect of transforming growth factor betal in cultured human peritoneal mesothelial cells[ J ]. Chin Med J, 2007, 120 : 230 - 237. 被引量:1
  • 5Bergstrom J, Lindholm B, Lacson E Jr, et al. What are the causes and consequences of the chronic inflammatory state in chronic dial- ysis patients[J]. Semin Dial, 2000, 13(3): 163-175. 被引量:1
  • 6Bergstrfim J. Lindholm B. Malnutrition, cardiac disease, and mortality[ J ]. Perit Dial Int, 1999, 19 ( Suppl 2) : $309 - 314. 被引量:1
  • 7Silaruks S, Sirivongs D, Chunlertrith D. Left ventricular hypertro- phy and clinical outcome in CAPD patients [ J ], Petit Dial Int, 2000, 20 (4) : 461 - 466. 被引量:1
  • 8刘伏友.腹膜透析患者的容量负荷问题[J].中国血液净化,2009,8(5):238-240. 被引量:11
  • 9纪天蓉,张桂红,任野平,李淑英,孔凡武.腹膜透析对心脏结构及功能的影响[J].中华肾脏病杂志,2010,26(6):468-469. 被引量:3
  • 10郭宝春,江心艳,张欣洲,贺晓蕾,王向阳,郑学,李涌泉,李雄根.腹透液总蛋白量是持续不卧床腹膜透析患者新发心血管事件的预测因子[J].中华肾脏病杂志,2010(11):829-833. 被引量:7

共引文献14

同被引文献64

  • 1王朝华,刘翔,柴晓丽.硝普钠联合多巴胺治疗心衰的临床效果及可行性观察[J].临床研究,2014,22(9):79-80. 被引量:1
  • 2蹇在金.老年人心力衰竭的病因及诊断[J].中华老年医学杂志,2005,24(2):156-158. 被引量:70
  • 3邱焕珍.硝普钠与硝酸甘油治疗重症心衰的疗效对.比[J].中国保健营养(下旬刊),2014, 25(1): 401-402. 被引量:1
  • 4陈德波.硝普钠联合多巴胺治疗对心衰患者氨基末端脑钠肽前体的影响[J].健康必读(下旬刊),2012,25(11): 39. 被引量:1
  • 5Grassmann A,Gioberge S,Moeller S,et al.ESRD patients in 2004:global overview of patient numbers,treatment modalities and associated trends[J].Nephrol Dial Transplant,2005,20(12):2587-2593. 被引量:1
  • 6Dukkipati R,Kopple JD.Causes and prevention of proteinenergy wasting in chronic kidney failure[J].Semin Nephrol,2009,29(1):39-49. 被引量:1
  • 7Wang AY,Lam CW,Yu CM,et al.Terminal pro-brain natriuretic peptide:an independent risk predictor of cardiovascular congestion,mortality,and adverse cardiovascular outcomes in chronic peritoneal dialysis patients[J].J Am Soc Nephrol,2007,18(1):321-330. 被引量:1
  • 8Grassmann A,Gioberge S,Moeller S,et al.ESRD patients in 2004:global overview of patient numbers,treatment modalities and associated trends[J].Nephrol Dial Transplant,2005,20(12):2587-2593. 被引量:1
  • 9Dukkipati R,Kopple JD.Causes and prevention of proteinenergy wasting in chronic kidney failure[J].Semin Nephrol,2009,29(1):39-49. 被引量:1
  • 10Wang AY,Lam CW,Yu CM,et al.Terminal pro-brain natriuretic peptide:an independent risk predictor of cardiovascular congestion,mortality,and adverse cardiovascular outcomes in chronic peritoneal dialysis patients[J].J Am Soc Nephrol,2007,18(1):321-330. 被引量:1

引证文献6

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部